Sang-Yoon Lee has extensive work experience in the field of medical research and development. Sang-Yoon currently serves as the CMO Head of Oncology at Bridge Biotherapeutics, Inc., where they are responsible for managing clinical trial operations and ensuring patient safety. Prior to this role, Lee was the CMO Head of R&D Center at Interpark Bio Convergence Center, where they led the organization's transformation into a new drug development entity. Sang-Yoon has also held leadership positions at HANDOK, Crystal Genomics Inc., Samsung Bioepis, and Pfizer, where they oversaw medical affairs and played a crucial role in the successful commercialization of various oncology drugs. Lee's experience also includes clinical fellowships at Seoul National University Hospital and serving as an Army Physician in the Republic of Korea Army. Sang-Yoon holds a strong academic background, having completed their residency and internship in Internal Medicine at Seoul National University Hospital.
Sang-Yoon Lee attended Seoul National University from 1992 to 1998, majoring in "International Relations." Prior to that, from 1989 to 1992, they studied at Hanyang High School in Seoul. Before high school, they attended Buam Middle School from 1986 to 1989. Sang-Yoon Lee's education began at Yeoksam Elementary School in Seoul from 1980 to 1986. Additionally, they briefly attended Jinhwa Girls' Middle School in Seoul in 1979.
Sign up to view 0 direct reports
Get started